Cite
Nguyen LC, Bakerlee CW, McKelvey TG, et al. Evaluating Use Cases for Human Challenge Trials in Accelerating SARS-CoV-2 Vaccine Development. Clin Infect Dis. 2021;72(4):710-715doi: 10.1093/cid/ciaa935.
Nguyen, L. C., Bakerlee, C. W., McKelvey, T. G., Rose, S. M., Norman, A. J., Joseph, N., Manheim, D., McLaren, M. R., Jiang, S., Barnes, C. F., Kinniment, M., Foster, D., Darton, T. C., & Morrison, J. (2021). Evaluating Use Cases for Human Challenge Trials in Accelerating SARS-CoV-2 Vaccine Development. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72(4), 710-715. https://doi.org/10.1093/cid/ciaa935
Nguyen, Linh Chi, et al. "Evaluating Use Cases for Human Challenge Trials in Accelerating SARS-CoV-2 Vaccine Development." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 72,4 (2021): 710-715. doi: https://doi.org/10.1093/cid/ciaa935
Nguyen LC, Bakerlee CW, McKelvey TG, Rose SM, Norman AJ, Joseph N, Manheim D, McLaren MR, Jiang S, Barnes CF, Kinniment M, Foster D, Darton TC, Morrison J. Evaluating Use Cases for Human Challenge Trials in Accelerating SARS-CoV-2 Vaccine Development. Clin Infect Dis. 2021 Feb 16;72(4):710-715. doi: 10.1093/cid/ciaa935. PMID: 32628748; PMCID: PMC7454474.
Copy
Download .nbib